1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-764802
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NSABP-C-06, NCT00378716
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCCRC-2993, NCI-V83-0142
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-92037A1, NCI-V92-0097
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 20 to 85
Sponsor: Other
Protocol IDs: CRC-A02-I, II, NCT00677612
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DFCI-96082, BMS-CA146-020, MGH-M6-37, NCI-G98-1384
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7619
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7634
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-19676
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-20276
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-22077
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-24577
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2575-II
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7552
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16961
|
|
16.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TPU-S1108, NCT00400023
|
|
17.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7736
|
|
18.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7653A
|
|
19.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7751
|
|
20.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7752
|
|
21.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7920
|
|
22.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7917
|
|
23.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7515
|
|
24.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7513
|
|
25.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: NCOG-3P62
|
